000 | 02007 a2200577 4500 | ||
---|---|---|---|
005 | 20250517002030.0 | ||
264 | 0 | _c20150629 | |
008 | 201506s 0 0 eng d | ||
022 | _a1555-2101 | ||
024 | 7 |
_a10.4088/JCP.14m09044 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFoa, Edna B | |
245 | 0 | 0 |
_aSix-month outcomes from a randomized trial augmenting serotonin reuptake inhibitors with exposure and response prevention or risperidone in adults with obsessive-compulsive disorder. _h[electronic resource] |
260 |
_bThe Journal of clinical psychiatry _cApr 2015 |
||
300 |
_a440-6 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImplosive Therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aObsessive-Compulsive Disorder _xdiagnosis |
650 | 0 | 4 |
_aRisperidone _xadverse effects |
650 | 0 | 4 |
_aSelective Serotonin Reuptake Inhibitors _xadverse effects |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aSimpson, Helen Blair | |
700 | 1 | _aRosenfield, David | |
700 | 1 | _aLiebowitz, Michael R | |
700 | 1 | _aCahill, Shawn P | |
700 | 1 | _aHuppert, Jonathan D | |
700 | 1 | _aBender, James | |
700 | 1 | _aMcLean, Carmen P | |
700 | 1 | _aMaher, Michael J | |
700 | 1 | _aCampeas, Raphael | |
700 | 1 | _aHahn, Chang-Gyu | |
700 | 1 | _aImms, Patricia | |
700 | 1 | _aPinto, Anthony | |
700 | 1 | _aPowers, Mark B | |
700 | 1 | _aRodriguez, Carolyn I | |
700 | 1 | _aVan Meter, Page E | |
700 | 1 | _aVermes, Donna | |
700 | 1 | _aWilliams, Monnica T | |
773 | 0 |
_tThe Journal of clinical psychiatry _gvol. 76 _gno. 4 _gp. 440-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.4088/JCP.14m09044 _zAvailable from publisher's website |
999 |
_c24334359 _d24334359 |